Albumin And Creatinine Tests Market Report 2026

Albumin And Creatinine Tests Market Overview

• Albumin And Creatinine Tests market size has reached to $3.6 billion in 2025 • Expected to grow to $9.65 billion in 2030 at a compound annual growth rate (CAGR) of 21.7% • Growth Driver: Impact Of Chronic Kidney Diseases Growth Of The Market • Market Trend: Advancements In Smartphone-Enabled Diagnostics Enhance Accuracy And Accessibility In Albumin And Creatinine Testing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Albumin And Creatinine Tests Market?

Albumin and creatinine tests refer to the tests that combine these two values to offer a more accurate evaluation of kidney health by comparing the concentrations of albumin and creatinine in urine samples. This ratio serves to adjust albumin levels based on creatinine levels, which might change depending on factors such as hydration level. The main types of products in albumin and creatinine tests are dipsticks and kits, analyzers, cartridges, reagents, and others. Dipsticks and kits are important tools for assessing kidney function, especially in identifying albuminuria, which is a critical symptom of chronic kidney disease. The different types are blood and urine creatinine, urine albumin, and glycated albumin and are used by end users such as hospitals and clinics, diagnostic laboratories, research laboratories and institutes, and others.

What Is The Albumin And Creatinine Tests Market Growth Forecast?

The albumin and creatinine tests market size is expected to see exponential growth in the next few years. It will grow to $9.65 billion in 2030 at a compound annual growth rate (CAGR) of 21.7%. The growth in the forecast period can be attributed to technological advancements in urine analyzers and cartridges, expansion of automated laboratory solutions, increasing adoption of glycated albumin testing, growing investment in diagnostic reagent innovation, integration of data analytics for early kidney disease detection. Major trends in the forecast period include increasing adoption of point-of-care albumin and creatinine tests, rising demand for automated urine analyzers, expansion of microalbumin test kits in early kidney disease detection, growing use of colorimetric and immunoassay reagents, enhanced accuracy through standardized calibration and control solutions.

Global Albumin And Creatinine Tests Market Segmentation

1) By Product: Dipsticks And Kits, Analyzers, Cartridges, Reagents, Other Products 2) By Test Parameter: Blood And Urine Creatinine, Urine Albumin 3) By End-User: Hospital And Clinics, Diagnostic Laboratories, Research Laboratories And Institutes, Other End-User Subsegments: 1) By Dipsticks And Kits: Urine Dipstick Tests, Microalbumin Test Kits, Point-of-Care Test Kits 2) By Analyzers: Automated Urine Analyzers, Benchtop Analyzers, Handheld Analyzers 3) By Cartridges: Single-Use Cartridges, Multi-Parameter Cartridges 4) By Reagents: Colorimetric Reagents, Enzymatic Reagents, Immunoassay Reagents 5) By Other Products: Control Solutions, Calibration Standards, Accessories And Consumables

What Is The Driver Of The Albumin And Creatinine Tests Market?

The rising incidence of chronic kidney diseases is expected to propel the growth of the albumin and creatinine tests market going forward. Chronic kidney disease (CKD) refers to the gradual loss of kidney function over time, where the kidneys are unable to filter waste and excess fluids from the blood effectively, leading to a buildup of toxins and potentially causing complications in various bodily systems. The rising incidence of chronic kidney diseases is driven by a rise in risk factors such as diabetes, hypertension, and obesity. Albumin and creatinine tests help diagnose and monitor chronic kidney diseases by measuring protein levels, such as albumin, in the urine and assessing kidney function through creatinine levels, enabling early detection and management of kidney damage. For instance, in June 2023, according to the report published by Kidney Research UK, a UK-based non-profit organization, currently, around 7.2 million people in the UK, accounting for over 10% of the population, are living with chronic kidney disease. This includes 3.25 million in advanced stages and 3.9 million in early stages. By 2033, the number of individuals affected is expected to increase to 7.61 million. Therefore, the rising incidence of chronic kidney disease is driving the growth of the albumin and creatinine tests industry.

Key Players In The Global Albumin And Creatinine Tests Market

Major companies operating in the albumin and creatinine tests market are Siemens Healthineers Company, Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, FUJIFILM Corporation, Laboratory Corporation of America Holdings, Sysmex Corporation, Ortho Clinical Diagnostics Inc., Randox Laboratories Ltd., Nova Biomedical Corporation, Eagle Biosciences Inc., Sekisui Diagnostics LLC, BTNX Inc., RayBiotech Life Inc., ARKRAY Inc., PromoCell GmbH, Arbor Assays Inc., Teco Diagnostics Inc., J. Mitra & Co. Pvt. Ltd., Anamol Laboratories Pvt. Ltd.

Global Albumin And Creatinine Tests Market Trends and Insights

Major companies operating in the albumin and creatinine tests market are focusing on developing advanced digital diagnostic solutions, such as smartphone-enabled uACR testing, to improve early detection of chronic kidney disease and expand patient access to at-home testing. Smartphone-enabled uACR testing utilizes mobile phone cameras, AI-driven analysis, and test strips to measure the urine albumin-to-creatinine ratio, providing rapid and reliable results without requiring in-clinic visits. For instance, in November 2024, Healthy.io, an Israel-based digital diagnostics company, presented new clinical study findings at ASN Kidney Week 2024, demonstrating that its smartphone-enabled Minuteful Kidney test delivers accuracy comparable to laboratory analyzers for measuring uACR. The study showed that the AI-powered test reliably identified elevated albumin levels and supported early CKD detection, helping reduce barriers to testing and enabling proactive kidney health management.

What Are Latest Mergers And Acquisitions In The Albumin And Creatinine Tests Market?

In February 2024, Everly Health, a US-based digital health and remote diagnostics company, partnered with the National Kidney Foundation (NKF) to expand access to at-home urine albumin-to-creatinine ratio (uACR) testing for early detection of chronic kidney disease. Through this partnership, Everly Health aims to enhance its kidney health screening capabilities by integrating uACR and estimated glomerular filtration rate (eGFR) measures into its diagnostic offerings for health plans and employers, while the NKF supports education, awareness, and outreach initiatives to improve early detection among underserved populations. The National Kidney Foundation is a US-based non-profit organization focused on kidney health and disease prevention.

Regional Outlook

North America was the largest region in the albumin and creatinine tests market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Albumin And Creatinine Tests Market?

The albumin and creatinine tests market consists of revenues earned by entities by providing services such as diagnostic testing services, home testing kits, automated test solutions, and data analysis and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The albumin and creatinine tests market also includes sales of reagents and consumables, testing instruments, home test kits, and software solutions. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Albumin And Creatinine Tests Market Report 2026?

The albumin and creatinine tests market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the albumin and creatinine tests industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.